Cargando…

Clinical and Endoscopic Differences Between Patients With Barrett’s Esophagus With and Without Dysplasia/Adenocarcinoma

Introduction: Barrett's esophagus (BE) is the main precursor of esophageal adenocarcinoma (EAC). This study aimed to identify the risk factors associated with BE progression to dysplasia or EAC in a Latin population. Methods: The study is a retrospective analysis of a single-center cohort of pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Valdovinos-Andraca, Francisco, Bartnicki-Navarrete, Isaac, Bernal-Mendez, Ambrosio R, Rafael Barreto-Zuñiga, Rafael, Romano-Munive, Adriana F, Gamboa-Domínguez, Armando, Elizondo-Rivera, Javier, Briseño-García, Daniel, Tellez-Ávila, Felix I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617646/
https://www.ncbi.nlm.nih.gov/pubmed/37916254
http://dx.doi.org/10.7759/cureus.46323
_version_ 1785129621862219776
author Valdovinos-Andraca, Francisco
Bartnicki-Navarrete, Isaac
Bernal-Mendez, Ambrosio R
Rafael Barreto-Zuñiga, Rafael
Romano-Munive, Adriana F
Gamboa-Domínguez, Armando
Elizondo-Rivera, Javier
Briseño-García, Daniel
Tellez-Ávila, Felix I
author_facet Valdovinos-Andraca, Francisco
Bartnicki-Navarrete, Isaac
Bernal-Mendez, Ambrosio R
Rafael Barreto-Zuñiga, Rafael
Romano-Munive, Adriana F
Gamboa-Domínguez, Armando
Elizondo-Rivera, Javier
Briseño-García, Daniel
Tellez-Ávila, Felix I
author_sort Valdovinos-Andraca, Francisco
collection PubMed
description Introduction: Barrett's esophagus (BE) is the main precursor of esophageal adenocarcinoma (EAC). This study aimed to identify the risk factors associated with BE progression to dysplasia or EAC in a Latin population. Methods: The study is a retrospective analysis of a single-center cohort of patients with BE, evaluated from 2002 to 2012. Results: We identified 420 patients with BE; 281 (66.9%) of them were men with a mean age of 57.2 ± 15.3 years. Among all BE patients evaluated, 81 (19.3%) had progression to some degree of dysplasia/EAC. The mean follow-up was 5.6 years. Multivariate analysis showed that age (OR = 1.03), cigarette smoking (OR = 3.05), long-segment BE (OR = 4.81), and a visible lesion on BE (OR = 6.94) were associated with progression to dysplasia/EAC. Conclusion: In Latin patients with BE, age, cigarette smoking, long-segment BE, and the presence of lesions were associated with the presence of dysplasia/EAC.
format Online
Article
Text
id pubmed-10617646
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-106176462023-11-01 Clinical and Endoscopic Differences Between Patients With Barrett’s Esophagus With and Without Dysplasia/Adenocarcinoma Valdovinos-Andraca, Francisco Bartnicki-Navarrete, Isaac Bernal-Mendez, Ambrosio R Rafael Barreto-Zuñiga, Rafael Romano-Munive, Adriana F Gamboa-Domínguez, Armando Elizondo-Rivera, Javier Briseño-García, Daniel Tellez-Ávila, Felix I Cureus Gastroenterology Introduction: Barrett's esophagus (BE) is the main precursor of esophageal adenocarcinoma (EAC). This study aimed to identify the risk factors associated with BE progression to dysplasia or EAC in a Latin population. Methods: The study is a retrospective analysis of a single-center cohort of patients with BE, evaluated from 2002 to 2012. Results: We identified 420 patients with BE; 281 (66.9%) of them were men with a mean age of 57.2 ± 15.3 years. Among all BE patients evaluated, 81 (19.3%) had progression to some degree of dysplasia/EAC. The mean follow-up was 5.6 years. Multivariate analysis showed that age (OR = 1.03), cigarette smoking (OR = 3.05), long-segment BE (OR = 4.81), and a visible lesion on BE (OR = 6.94) were associated with progression to dysplasia/EAC. Conclusion: In Latin patients with BE, age, cigarette smoking, long-segment BE, and the presence of lesions were associated with the presence of dysplasia/EAC. Cureus 2023-10-01 /pmc/articles/PMC10617646/ /pubmed/37916254 http://dx.doi.org/10.7759/cureus.46323 Text en Copyright © 2023, Valdovinos-Andraca et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Gastroenterology
Valdovinos-Andraca, Francisco
Bartnicki-Navarrete, Isaac
Bernal-Mendez, Ambrosio R
Rafael Barreto-Zuñiga, Rafael
Romano-Munive, Adriana F
Gamboa-Domínguez, Armando
Elizondo-Rivera, Javier
Briseño-García, Daniel
Tellez-Ávila, Felix I
Clinical and Endoscopic Differences Between Patients With Barrett’s Esophagus With and Without Dysplasia/Adenocarcinoma
title Clinical and Endoscopic Differences Between Patients With Barrett’s Esophagus With and Without Dysplasia/Adenocarcinoma
title_full Clinical and Endoscopic Differences Between Patients With Barrett’s Esophagus With and Without Dysplasia/Adenocarcinoma
title_fullStr Clinical and Endoscopic Differences Between Patients With Barrett’s Esophagus With and Without Dysplasia/Adenocarcinoma
title_full_unstemmed Clinical and Endoscopic Differences Between Patients With Barrett’s Esophagus With and Without Dysplasia/Adenocarcinoma
title_short Clinical and Endoscopic Differences Between Patients With Barrett’s Esophagus With and Without Dysplasia/Adenocarcinoma
title_sort clinical and endoscopic differences between patients with barrett’s esophagus with and without dysplasia/adenocarcinoma
topic Gastroenterology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617646/
https://www.ncbi.nlm.nih.gov/pubmed/37916254
http://dx.doi.org/10.7759/cureus.46323
work_keys_str_mv AT valdovinosandracafrancisco clinicalandendoscopicdifferencesbetweenpatientswithbarrettsesophaguswithandwithoutdysplasiaadenocarcinoma
AT bartnickinavarreteisaac clinicalandendoscopicdifferencesbetweenpatientswithbarrettsesophaguswithandwithoutdysplasiaadenocarcinoma
AT bernalmendezambrosior clinicalandendoscopicdifferencesbetweenpatientswithbarrettsesophaguswithandwithoutdysplasiaadenocarcinoma
AT rafaelbarretozunigarafael clinicalandendoscopicdifferencesbetweenpatientswithbarrettsesophaguswithandwithoutdysplasiaadenocarcinoma
AT romanomuniveadrianaf clinicalandendoscopicdifferencesbetweenpatientswithbarrettsesophaguswithandwithoutdysplasiaadenocarcinoma
AT gamboadominguezarmando clinicalandendoscopicdifferencesbetweenpatientswithbarrettsesophaguswithandwithoutdysplasiaadenocarcinoma
AT elizondoriverajavier clinicalandendoscopicdifferencesbetweenpatientswithbarrettsesophaguswithandwithoutdysplasiaadenocarcinoma
AT brisenogarciadaniel clinicalandendoscopicdifferencesbetweenpatientswithbarrettsesophaguswithandwithoutdysplasiaadenocarcinoma
AT tellezavilafelixi clinicalandendoscopicdifferencesbetweenpatientswithbarrettsesophaguswithandwithoutdysplasiaadenocarcinoma